title: Heteroploid conversion of human skin cells by methylcholanthrene.
abstract: Cultured epithelial cells from human skin generally had 3- to 30-fold more hydrocarbon-metabolizing activity than fibroblasts from skin of the same donor. This activity was constant for up to 55 days in primary culture but was lost rapidly upon physical subdivision of the cultures. Treatment of primary mixed fibroblasts and epithelial cell cultures with methylcholanthrene, but not phenanthrene, led to development of actively growing fibroblastic cultures with many heteroploid cells. Unique marker chromosomes, stable over a number of cell population doublings, were identified in several of the heteroploid cell strains. Pure cultures of fibroblasts from the same donors did not undergo heteroploid conversion in response to methylcholanthrene. Spontaneously occurring heteroploidy in logarithmic phase human fibroblasts is a rare event; thus, heteroploid conversion may be a useful marker for chemical transformation of human cells. Because methylcholanthrene seems to have little transforming effect on human skin fibroblasts, human skin epithelial cells, because of their hydrocarbon-metabolizing activity, may serve to convert methylcholanthrene from a distal to an ultimate carcinogenic form.
mesh_terms: D000293:Adolescent; D000782:Aneuploidy; D001973:Bromodeoxyuridine / Q000494:pharmacology; D002478:Cells, Cultured; D002648:Child; D002875:Chromosomes / Q000187:drug effects / Q000502:physiology; D004848:Epithelium / Q000502:physiology; D005260:Female; D005347:Fibroblasts / Q000502:physiology; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008748:Methylcholanthrene / Q000494:pharmacology*; D012867:Skin / Q000187:drug effects; D012879:Skin Physiological Phenomena
chemical_list: D008748:Methylcholanthrene; D001973:Bromodeoxyuridine
references.citation: Virology. 1964 Jun;23:291-4
references.pmid: 14187925
references.citation: Cancer Res. 1971 Sep;31(9):1206-9
references.pmid: 5115050
references.citation: In Vitro. 1974 Jul-Aug;10:18-25
references.pmid: 4471175
references.citation: Cell. 1975 Oct;6(2):245-52
references.pmid: 1182804
references.citation: Lancet. 1971 Oct 30;2(7731):971-2
references.pmid: 4107917
references.citation: Nat New Biol. 1973 Jun 20;243(129):247-50
references.pmid: 4515180
references.citation: Lancet. 1967 Apr 22;1(7495):897
references.pmid: 4164388
references.citation: J Natl Cancer Inst. 1973 Nov;51(5):1417-23
references.pmid: 4357758
references.citation: Humangenetik. 1973 Apr 16;18(2):185-7
references.pmid: 4578385
references.citation: Arch Surg. 1974 May;108(5):724-9
references.pmid: 4597960
references.citation: Arch Surg. 1974 May;108(5):721-3
references.pmid: 4597959
references.citation: Nature. 1974 Dec 13;252(5484):610-2
references.pmid: 4431526
references.citation: Am J Hum Genet. 1973 May;25(3):327-31
references.pmid: 4704864
references.citation: J Natl Cancer Inst. 1972 Aug;49(2):585-90
references.pmid: 5076831
references.citation: In Vitro. 1975 May-Jun;11(3):117-29
references.pmid: 809348
references.citation: In Vitro. 1976 May;12(5):352-62
references.pmid: 780259
references.citation: J Cell Physiol. 1976 Jan;87(1):89-100
references.pmid: 1245560
references.citation: Cancer Res. 1975 Dec;35(12):3551-7
references.pmid: 1192420
references.citation: Nature. 1975 Jul 24;256(5515):322-4
references.pmid: 1143334
references.citation: J Natl Cancer Inst. 1975 Jan;54(1):157-62
references.pmid: 1113299
references.citation: Proc Natl Acad Sci U S A. 1963 Aug;50:390-5
references.pmid: 14060661